The interrelationship between cytotoxin-associated gene A, vacuolating cytotoxin, and Helicobacter pylori-related diseases

Journal of Infectious Diseases

Volumn 173, Issue 5, 1996, Pages 1171-1175

  Weel, Jan F L ^a   Van Der Hulst, René W M ^a   Gerrits, Yvette ^a   Roorda, Philip ^a   Feller, Monique ^a   Dankert, Jacob ^a   Tytgat, Guido N J ^a   Van Der Ende, Arie ^a  

^a UNIVERSITY OF AMSTERDAM   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

BACTERIUM ANTIBODY; CYTOTOXIN; CYTOTOXIN ASSOCIATED GENE A; UNCLASSIFIED DRUG; VACUOLATING CYTOTOXIN VAC A;

ARTICLE; BACTERIAL VIRULENCE; BACTERIUM ISOLATION; DYSPEPSIA; GRAM NEGATIVE INFECTION; HELICOBACTER PYLORI; HUMAN; HUMAN TISSUE; MAJOR CLINICAL STUDY; PEPTIC ULCER; PRIORITY JOURNAL;

EID: 0029953751     PISSN: 00221899     EISSN: None     Source Type: Journal    
DOI: 10.1093/infdis/173.5.1171     Document Type: Article

References (32)

1. Megraud F. Epidemiology of Helicobacter pylori infection. Gastroenterol Clin North Am 1993;22:73-88.
2. NIH consensus conference. Helicobacter pylori in peptic ulcer disease. NIH Consensus Development Panel on Helicobactor pylori in Peptic Ulcer Disease. JAMA 1994;272:65-9.
3. Marshall B. Helicobacter pylori. Am J Gastroenterol 1994; 89(suppl):S116-28.
4. Graham DY, Lew GM, Klein PD, et al. Effect of treatment of Helicobacter pylori infection on the long-term recurrence of gastric and duodenal ulcer. A randomized, controlled study. Ann Intern Med 1992;116: 705-8.
5. Parsonnet J, Hansen S, Rodriquez L, Gelb AB, Warnke RA, Jellum E. Helicobacter pylori infection and gastric lymphoma. N Engl J Med 1994;330:1267-71.
6. Roggero E, Zucca E, Pinotti G, et al. Eradication of Helicobacter pylori infection in primary low-grade gastric lymphoma of mucosa-associated lymphoid tissue. Ann Intern Med 1995;122:767-9.
7. Kuipers EJ, Uyterlinde AM, Peña AS, et al. Long term sequelae of Helicobacter pylori gastritis. Lancet 1995;345:1525-8.
8. Eaton KA, Morgan D, Krakowa S. Motility as a factor in the colonisation of gnotobiotic piglets by Helicobacter pylori. J Med Microbiol 1992;37:123-7.
9. Eaton KA, Brooks CL, Morgan DR, Krakowa S. Essential role of urease in the pathogenesis of gastritis induced by Helicobacter pylori in gnotobiotic piglets. Infect Immun 1991;59:2470-5.
10. Telford JL, Ghiara P, Dell'Orco M. Gene structure of the Helicobacter pylori cytotoxin and its key role in gastric disease. J Exp Med 1994;179:1653-8.
11. Crabtree JE, Taylor JD, Wyatt JI, Heatley RV, Shallcross TM, Tompkins DS. Mucosal IgA recognition of Helicobacter pylori 120 kDa protein, peptic ulceration, and gastric pathology. Lancet 1991;338:332-5.
12. Crabtree JE, Wyatt JI, Sobala GM, Miller G, Tompkins DS, Primrose JN. Systemic and mucosal humoral responses to Helicobacter pylori in gastric cancer. Gut 1993;34:1339-43.
13. Blaser MJ, Pérez-Pérez GI, Kleanthous H, et al. Infection with Helicobacter pylori strain cagA is associated with an increased risk of developing gastric adenocarcinoma of the stomach. Cancer Res 1995; 55:2111-5.
14. van der Ende A, Rauws EAJ, Feller M, Mulder CJJ, Tytgat GNJ, Dankert J. Infection by a mixed population, including for cagA, of Helicobacter pylori [abstract]. Gut 1995;37(suppl 1):A68.
15. Langenberg W, Rauws EAJ, Widjojokusumo A, Tytgat GNJ, Zanen HC. Identification of Campylobacter pyloridis isolates by restriction endonuclease DNA analysis. J Clin Microbiol 1986;24:414-7.
16. Oudbier JH, Langenberg W, Rauws EAJ, Bruin-Mosch C. Genotypical variation of Campylobacter pylori from gastric mucosa. J Clin Microbiol 1990;28:559-65.
17. Covacci A, Censini S, Bugnoli M, et al. Molecular characterization of the 128-kDa immunodominant antigen of Helicobacter pylori associated with cytotoxicity and duodenal ulcer. Proc Natl Acad Sci USA 1993;90:5791-7.
18. Sambrook, J, Fritsch, EF, Maniatis, T. Molecular cloning: a laboratory manual. Cold Spring Harbor, NY: Cold Spring Harbor Laboratory Press, 1989.
19. Wilke H, Harstrick A, Meyer HJ, et al. Etablierung eines Panels van humanen heterotransplantierten Magenkarzinomen - ein präklinisches Modell. In: Schmoll HJ, Pichlmayr R, eds. Aktuelle Therapie gastrointestinaler Tumoren. Heidelberg: Springer, 1992:158-63.
20. Leunk RD, Johnson PT, David BC, Kraft WG, Morgan DR. Cytotoxic activity in broth-culture filtrates of Campylobacter pylori. J Med Microbiol 1988;26:93-9.
21. Hosmer DW, Lemeshow S. Applied logistic regression. New York: John Wiley & Sons, 1989.
22. Owen RJ, Hurtado A, Banatvala N, et al. Conservation of the cytotoxin-associated (cagA) gene of Helicobacter pylori and investigation of association with vacuolating-cytotoxin activity and gastroduodenal disease. FEMS Immunol Med Microbiol 1994;9:307-16.
23. Xiang Z, Censini S, Bayeli PF, et al. Analysis of expression of CagA and VacA virulence factors in 43 strains of Helicobacter pylori reveals that clinical isolates can be divided into two major types and that CagA is not necessary for expression of the vacuolating cytotoxin. Infect Immun 1995;63:94-8.
24. + Helicobacter pylori strains. J Clin Microbiol 1995;33: 1496-500.
25. Crabtree JE, Farmery SM, Lindley IJD, Figura N, Peichl P, Tompkins DS. CagA/cytotoxic strains of Helicobacter pylori and interleukin-8 in gastric epithelial cell lines. J Clin Pathol 1994;47:945-50.
26. Papini E, Bugnoli M, De Bernard M, Figura N, Rappuoli R, Montecucco C. Bafilomycin A1 inhibits Helicobacter pylori-induced vacuolization of Hela cells. Mol Microbiol 1993;7:323-7.
27. Cover TL, Blaser MJ. Purification and characterization of the vacuolating toxin from Helicobacter pylori. J Biol Chem 1992;267:10570-5.
28. Figura N, Guglielmetti P, Rossolini A, et al. Cytotoxin production by Campylobacter pylori strains isolated from patients with peptic ulcers and from patients with chronic gastritis only. J Clin Microbiol 1989;27:225-6.
29. Rautelin H, Blomberg B, Jarnerot G, Danielson D. Nonopsonic activation of neutrophils and cytotoxin production by Helicobacter pylori: ulcerogenic markers. Scan J Gastroenterol 1994;29:128-32.
30. Tee W, Lambert JR, Pegorer M, Dwyer B. Cytotoxin production by Helicobacter pylori more common in peptic ulcer disease [abstract]. Gastroenterology 1993;104:A789.
31. Tummuru MKR, Cover TL, Blaser MJ. Mutation of the cytotoxin associated cagA gene does not affect the vacuolating cytotoxin activity of Helicobacter pylori. Infect Immun 1994;62:2609-13.
32. Marchetti M, Arico B, Burroni D, Figura N, Rappuoli R, Ghiara P. Development of a mouse model of Helicobacter pylori infection that mimics human disease. Science 1995;267:1655-8.